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Background: Over the last few years, new treatments for a damaged intervertebral disc (IVD) have included
strategies to repair, replace, or regenerate the degenerative disc. However, these techniques are likely to have
limited success, due to insufficiently effective means to address the damaged anulus fibrosus (AF). Here, we try to
develop a bioprocess method for decellularization of the xenogeneic AF tissue, with a view to developing a
scaffold as a potential candidate for clinical application in spinal surgery.
Methods: Porcine AFs were decellularized using freeze-thaw cycles, followed by various combined treatments with
0.1% sodium dodecyl sulfate (SDS) and nucleases.
Results: Hematoxylin and eosin (H & E) staining showed that decellularization was achieved through the
decellularization protocols. Biochemical analyses revealed 86% reduction in DNA, but only 15.9% reduction in
glycosaminoglycan (GAG) content, with no significant difference in the hydroxyproline content. There was no
appreciable cytotoxicity of the acellular AF. Biomechanical testing of the acellular AF found no significant decline in
stiffness or Young’s modulus.
Conclusions: Porcine AF tissues were effectively decellularized with the preservation of biologic composition and
mechanical properties. These results demonstrate that acellular AF scaffolds would be a potential candidate for
clinical application in spinal surgery.
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As the global population ages, degenerative disc disease
(DDD) and lower back pain affect millions of people
worldwide. Chronic back pain can manifest in relation
to several clinical conditions, including disc herniation,
radiculopathy, myelopathy, spinal stenosis, and instabil-
ity. There is significant evidence of links between DDD
and lower back pain although the pathogenesis of DDD
has yet to be fully delineated.
Although degeneration of the intervertebral disc (IVD)
is associated with the majority of cases of lower back
pain, current treatment options are palliative rather than
curative. Although the prevalent surgical procedures can* Correspondence: yyhuang@ntu.edu.tw
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unless otherwise stated.be successful in relieving back pain in the short term,
but they do not repair the disc nor restore the normal
biological and mechanical properties of the human
spine. Such procedures limit mobility or may otherwise
further alter the biomechanics of the spine, leading to
further degeneration of adjacent segments.
Discectomy is the most common surgical treatment of
lumbar disc herniation. However, subsequent disc de-
generation and recurrent disc herniation are major prob-
lems after surgery. To deal with DDD and damage of the
anulus during discectomy, anulus fibrosus (AF) repair
and reinforcement of the damaged AF, in addition to
spinal surgery, are desired. Although there are commer-
cially available implants for closing a damaged AF (the
Inclose©, the Xclose©, and the Barricaid©), these tech-
niques cannot prevent AF degeneration or maintain the
biological AF structure in the long term [1,2]. AF closure. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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strategies to prevent the NP replacement from leaking
out from the disc.
Because of the limited intrinsic healing capacity and
low cellularity of the AF, it is susceptible to degeneration
and poor repair, similarly to articular cartilage [2,3].
Therefore, tissue engineering would be an ideal candi-
date for repair or substitution of degenerated discs with
appropriate analogs. Several different types of biomate-
rials have been explored as possible candidates for AF
repair, but none mimic the mechanical properties and
compositional structure of AF [4,5]. An alternative strat-
egy for developing a biomaterial with tissue engineering
is to decellularize xenogeneic AF tissues by removing
the immunogenic cells. The objective of decellularization
is to remove all cellular and nuclear material while min-
imizing any adverse effect on the mechanical integrity,
biological activity, and composition of the remaining
scaffold. This method has been successfully utilized in
various fields of tissue engineering, including cartilage,
the meniscus, ligaments, and tendons [6,7].
Over the last few years, advanced development in the
field of tissue engineering has resulted in various poten-
tial new strategies to repair, replace, or regenerate the
degenerative disc [8-10]. Despite major advances, none
has yet succeeded in clinical therapy [4].
In an attempt to preserve the integrity of the AF and
to minimize damage to biomechanical functions of the
disc, anular repair seemed to be the easiest method to
achieve this goal [5]. Previously, we have described a
new anular repair after discectomy in IVD degeneration
[11]. While direct repair after discectomy can be expected
to reduce the risk of recurrent disc herniation and has
been shown to result in improved anular healing, the de-
velopment of new therapeutic strategies to augment dam-
aged AF tissues may offer new hope for alleviating chronic
low back pain when direct repair is not possible [12]. The
present study aims to develop a bioprocess method for
decellularization of the xenogeneic AF tissue and proceeds
to characterize the biochemical and biomechanical prop-
erties of a natural and acellular AF scaffold. The extent
of decellularization was determined using histological,
biochemical, and immune-histochemical techniques. The
biocompatibility and biomechanical properties of the
decellularized scaffold were also investigated to estab-
lish a potential protocol for clinical application.
Materials and methods
Tissue harvest
Fresh porcine lumbar spines were obtained en bloc from
a local abattoir (Taoyuan County, Taiwan) within 2 h post-
mortem. The AF samples were harvested from the IVD by
gently excising and washing in phosphate-buffered saline
(PBS) to remove excess blood. Samples were then placedin neutral-buffered formalin for histological analysis or
frozen and stored on a PBS moistened filter paper at −20°C.
Decellularization methods
Decellularization was based on the methods developed by
Booth et al. and modified by Stapleton [13,14]. Briefly, the
AF samples were decellularized by exposing the tissue to
five dry freeze-thaw cycles. The freezing step was at −80°C
for 22 h, followed by thawing in an incubator at 37°C for
2 h. Samples were then incubated in a hypotonic buffer
(10 mM Tris–HCl, pH 8.0), first at 4°C for 24 h, then at
37°C for 24 h, then in 0.1% sodium dodecyl sulfate (SDS;
Sigma-Aldrich) at 45°C for 48 h, with agitation in the
presence of protease inhibitors (aprotinin 10 KIU/mL;
Sigma-Aldrich). After washing, the samples were incu-
bated in DNase (50 U/mL; Sigma-Aldrich) and RNase
(1 U/mL; Sigma-Aldrich) in a buffer (50 mM Tris–HCl,
10 mM magnesium chloride, and 50 mg/mL bovine serum
albumin (BSA) at pH 7.5) for 3 h at 37°C with gentle agi-
tation. Tissues were then washed in PBS at 37°C for
8 h three times.
Histology
Tissue specimens were fixed in neutral-buffered formalin
for 48 h, then embedded in paraffin wax and sectioned at
6-μm thickness with a microtome. Samples were charac-
terized histologically using hematoxylin and eosin (H & E,
Bios Europe, Skelmersdale, United Kingdom) staining to
assay cellular content, sirius red staining to visualize colla-
gen distribution, and alcian blue staining to localize gly-
cosaminoglycan (GAG) content, as described by Stapleton
et al. [14].
Scanning electron microscopy (SEM)
Fresh-frozen AF and the decellularized AF scaffolds were
harvested and fixed in 4% paraformaldehyde (wt./vol.)
for 2 days. The samples underwent sequential dehydra-
tion and were sputtercoated with gold. Specimens were
then evaluated and imaged using a SEM (JSM 5600,
JEOL Ltd., Japan) to evaluate the ultrastructure of the
AF surfaces.
Determination of proteoglycan, collagen, and DNA
content
Sulfated glycosaminoglycan assay
The proteoglycan content of the tissue was determined
by measuring the amount of sulfated glycosamino-
glycans in the papain-digested tissue using the 1,9-
dimethylmethylene blue (DMMB; Sigma-Aldrich) dye
binding assay and spectrophotometry [15]. AF tissue
specimens were first lyophilized (n = 6, dry weight = 50 mg)
and then digested in papain buffer (250 μL papain in
PBS at pH 6.0 with 150 mM sodium chloride, 55 nM so-
dium citrate, 5 mM cysteine-HCl, and 5 mM Na2EDTA)
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530 nm using chondroitin sulfate as a standard.
Hydroxyproline assay
Collagen content was quantified using a commercially
available assay kit (Hydroxyproline assay kit, BioVision,
USA) [16]. AF specimens (n = 6) were first lyophilized
and then hydrolyzed in 6 M hydrochloric acid (HCl) at
120°C for 3 h and neutralized using sodium hydroxide
(NaOH). The hydroxyproline content was determined
using the chloramine-T reagent assay and read using
spectrophotometry at 560 nm. The concentration of hy-
droxyproline was then calculated by interpolation from a
hydroxyproline standard curve.
DNA assay
The residual cells were determined by DNA assay (ReliaPrep™
gDNA Tissue Miniprep System, Promega, USA) [17].
DNA was extracted from both fresh and decellularized
AF. Six AF specimens (wet weight = 25 mg) were used.
DNA was extracted using a DNA isolation kit and then
quantified according to the standard protocols by measur-
ing the absorbance at 260/280 nm in a spectrophotometer
(NanoDrop ND 1000, Thermo Fisher Scientific, United
Kingdom).
Cytotoxicity of decellularized AF in transwell insert model
Samples of decellularized AF were prepared and placed
at the bottom of transwell insert wells before cytotoxicity
testing. The transwells used in this study were 24 mm in
diameter, with a membrane pore size of 0.4 μm (Costar,
Transwell, Corning, NY, USA). The transwells were placedFigure 1 Parallel bone-AF-bone specimens. (A) Two parallel bone-AF-bo
vertebrae. (B) Bone-AF-bone biomechanics were assessed using a materialsonto 24-well culture plates, then seeded with NIH3T3
fibroblasts (2 × 103 cell/well) and incubated for 24, 48, and
72 h. Five wells per sample were prepared. In controls, cells
were cultured in 24-well plates with transwell inserts but
without any sample specimen. Following co-culture, the in-
sert wells were removed. The viability of the target NIH3T3
fibroblasts was estimated by the 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium (MTS, Promega, USA) assay at 490 nm [18].
Tensile test
Due to the anatomy and lamellar architecture of AF, it is
difficult to examine variation in mechanical properties
by tensile testing as it can be undertaken like a tendon.
We thus designed a bone-AF-bone specimen, to exam-
ine the differences in the mechanical properties before
and after decellularization by tensile testing, using a test-
ing protocol based on work by Woo et al. and Penn et al.
[19,20]. Two parallel bone-AF-bone specimens were ob-
tained from the same level disc and adjacent vertebrae
with a width of 5 mm, depth of 8 mm, and bone stump
length of approximately 15 mm (Figure 1A). Electronic
vernier calipers were used to measure the exact length
and cross-sectional area of the AF portion, and this value
was used in calculations of the specimen properties. From
the same disc, one sample was washed and stored at −20°C
before testing, the other subjected to the decellularization
procedure.
Bone-AF-bone biomechanics were assessed using a ma-
terials testing system (MTS, MTS Systems Corporation,
MN, USA) in a uni-axial tensile test configuration. The dis-
tal 1 cm of each specimen was secured in a custom madene specimens were obtained from the same level disc and adjacent
testing system.
Figure 2 Histology of anulus fibrosus (AF) with H & E stain. Cellular material is clearly visible in the fresh-frozen AF (A, B) and rare to absent
in the decellularized AF (C, D). (A) Fresh AF, ×40 magnification; (B) Fresh AF, ×100 magnification; (C) Decellularized AF, ×40 magnification;
(D) Decellularized AF, ×100 magnification.
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each test to ensure that no slippage occurred. At the be-
ginning of each test, the specimen was preconditioned by
running at 1 Hz at 1-mm displacement. Preconditioning
was followed by monotonic tensile test-to-failure at a rate
of 0.06 mm/s. Failure was defined as AF rupture or bone
stump breakage. Load–displacement data were recorded
at a frequency of 100 Hz by the MTS system. From theFigure 3 Fresh and decellularized anulus fibrosus (AF) stained with al
(B) Decellularized AF stained with alcian blue, ×40 magnification.load–displacement curves, stiffness and Young’s modulus
were obtained.
Data analysis
All numerical data were analyzed using Microsoft Excel
2010. Means, standard deviations, and 95% confidence
limits were calculated for each set of results. Data from
fresh and decellularized specimens were compared usingcian blue. (A) Fresh AF stained with alcian blue, ×40 magnification.
Figure 4 Fresh and decellularized anulus fibrosus (AF) stained with sirius red. (A) Fresh AF stained with sirius red, ×40 magnification.
(B) Decellularized AF stained with sirius red, ×40 magnification.
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statistical significance was p < 0.05.
Results
Histological analysis
In fresh AF tissue, H & E staining showed abundant
cellular material, specifically nuclear material, to be
embedded in the matrix (Figure 2A,B). In tissues subject
to decellularization, rare cellular material was shown
on H & E staining, as shown in Figure 2C,D.
Alcian blue staining revealed the GAGs to be present
over the entire fresh AF tissue in lamellar distribution
(Figure 3A). In contrast, the decellularized matrix showed
some qualitative loss of GAGs in all locations (Figure 3B).
Sirius red staining revealed plentiful collagen fibrils,
which were visible in both fresh and decellularized AF
without obvious changes in the morphology and distri-
bution (Figure 4A,B).
SEM analysis
SEM revealed the presence of small pore-like structures
on both the fresh AF and decellularized AF surfaces,Figure 5 SEM images of anulus fibrosus (AF). (A) Image of fresh AF, pre
AF, confirmed retention of pore-like structures on the AF surface, ×100 magnificconfirming retention of pore-like structures after decel-
lularization treatment (Figure 5A,B).Biochemical assays
Quantification of GAGs
The result indicated loss of 15.9% GAGs following decel-
lularization. However, there was no statistically signifi-
cant difference between the sulfated sugar content of the
fresh AF as compared to the decellularized AF (p > 0.05)
(Table 1).Quantification of hydroxyproline
There was no significant difference in the hydroxypro-
line content of the fresh AF in comparison with decellu-
larized AF (p > 0.05) (Table 1).Quantification of DNA
DNA content of the decellularized AF scaffolds was
significantly decreased by 86% when compared to the
untreated AF (p < 0.01) (Table 1).sence of pore-like structure, ×100 magnification. (B) Image of decellularized
ation.
Table 1 GAGs, hydroxyproline, and DNA contents of the
fresh and decellularized anulus fibrosus (AF)
Fresh AF (n = 6) Decellularized AF (n = 6)
GAGs (μg/mg) 13.90 ± 1.65 11.69 ± 1.74
Hydroxyproline (μg/mg) 98.65 ± 4.71 96.72 ± 3.33
DNA content (ng/mg) 31.58 ± 8.31 4.02 ± 1.56
Results given as mean ± SD.
Table 2 Biomechanical properties of fresh and
decellularized anulus fibrosus (AF)
Fresh AF (n = 5) Decellularized AF (n = 5)
Stiffness (N/mm) 22.24 ± 5.07 19.95 ± 6.53
Young’s modulus (MPa) 62.58 ± 9.19 60.7 ± 14.86
Results given as mean ± SD.
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The in vitro toxicity studies of the control and decellu-
larized AF were conducted by MTS assay with NIH3T3
cells. There was no statistically significant difference in
in vitro cytotoxicity of the decellularized AF in compari-
son with the negative control (p > 0.05) (Figure 6).
Tensile testing
From the load–displacement results of tensile testing,
stiffness and Young’s modulus were obtained (Table 2).
Tensile testing of the decellularized AF scaffolds showed a
tendency of reduction of stiffness and Young’s modulus
when compared to the untreated AF but that the differ-
ence was not statistically significant (p > 0.05). Specimens
that failed at the grips were excluded from calculations.
Discussion
We have reviewed various decellularization protocols
with different chemical, physical and enzymatic methods
[21-25]. At present, complete decellularization of tissue
will require a combination of physical, chemical, and en-
zymatic approaches [6]. Compared to a single freeze-thaw
treatment, the repeated freeze-thaw of tissues is known toFigure 6 Cytotoxicity studies of the control and decellularized anulus
the decellularized AF in comparison with the negative control. Control negproduce most cell destruction and has been used fre-
quently for decellularization of tendinous and ligamentous
tissue [23,26]. Following freezing, a subsequent incubation
in 0.1% (w/v) SDS and nucleases (RNase and DNase) is
used to solubilize the cellular remains. Finally, extensive
washing in PBS will further remove cell remnants and all
residual chemicals. Results of H & E staining showed that
decellularization was achieved through modified decellu-
larization protocols. To further verify the efficiency of cell
removal, DNA content was examined by quantitative
spectrophotometry. Results revealed 86% reduction in
DNA content in the decellularized AF scaffold when
compared to the non-treated AF tissue.
Following decellularization, it was important to deter-
mine the effects on the biochemical and biomechanical
properties of the decellularized scaffold, while preliminar-
ily evaluating its biocompatibility. GAGs and collagen are
extracellular matrix components, important for maintain-
ing the biologic and mechanical properties of AFs. Alcian
blue staining revealed that the GAGs were still present
after decellularization, but there seems to be partial quali-
tative loss. Loss of GAGs was further verified by sulfated
glycosaminoglycan assay, the results indicating that
15.9% GAGs were removed during the processing steps,
although there was no statistically significant differencefibrosus (AF). Data revealed no statistically significant difference of
ative control, DAF decellularized AF.
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the major stress-bearing component of fibrous tissue,
playing an important role in the tensile properties of the
AF tissue. Sirius red staining revealed that collagen fibrils
abound in both fresh and decellularized AF without gross
evidence of damage and distribution. Hydroxyproline is
one of the main elements of collagen and can thus be used
to determine the levels of collagen. Further investigation
revealed that there was no significant change in hydroxy-
proline content after decellularization.
Although the decellularization methods described above
include chemicals and enzymes, which are utilized for
their inherent abilities to destroy cells, if the chemicals
remain within the tissue after treatment, they may be toxic
to host cells while implanting in vivo. In an effort to
remove any remaining chemical and enzymatic reagents,
extensive washing in PBS at the end of the protocols was
applied. Simple in vitro cytotoxicity tests were performed
to examine the biocompatibility of decellularized AF
scaffolds, which indicated that any residual, potentially
cytotoxic reagents had been adequately removed by the
wash procedure.
A successful strategy for AF repair requires a clear un-
derstanding of the functional biomechanics of the disc.
The NP is highly pressurized and the AF prevents radial
disc bulge by generating large hoop stresses. Therefore,
AF repair materials need to withstand the high tensile
hoop stresses generated from NP pressurization and tensile
stresses resulting from spinal motion [4]. Tensile testing of
the decellularized AF demonstrated no significant differ-
ence in stiffness or Young’s modulus, further indicating to
the satisfactory preservation of biomechanics in compari-
son to the native tissue. These results demonstrate that the
decellularization protocol preserved desirable components
of the AF matrix, which suggests that acellular AF would
be a potential scaffold for clinical utility.
Although the above methods provide important infor-
mation regarding the effectiveness of the decellularization
methods, consideration must be given to the potential im-
mune response of small amounts of nuclear material or
cytoplasmic debris within the remaining scaffold mate-
rials. It has been found that the mammalian cell-surface
xenoantigen, α-Gal epitopes (Galα1,3-Galβ1-4GlcNAc-R),
can trigger a hyperacute rejection after transplant of living
animal tissue to humans. Various efforts had been carried
out to eliminate the α-Gal epitopes from xenograft to re-
duce the immune response. The α-Gal epitopes have been
found in small intestinal submucosa-extracellular matrix
(SIS-ECM), a biomaterial consisting of porcine small
intestinal submucosa [27]. To simulate the possible impli-
cations in human implantation, the role of α-Gal epitope in
the host immune response to SIS-ECM has been investi-
gated in previous studies. These demonstrated the presence
of anti-Gal antibody delays but that the immunomodulatoryeffect of Gal epitope does not adversely affect in vivo
remodeling of xenogeneic extracellular matrix (ECM)
[28,29]. Most commercially available biologic scaffold ma-
terials also contain trace amounts of remnant DNA, which
is typically present as small fragments and logically subject
to degradation via enzymatic breakdown [7,30]. That the
remaining DNA fragments and α-Gal epitopes are capable
of stimulating an immune reaction is well known, but it is
possible that a threshold amount of material is required to
adversely affect the remodeling response [31]. It is unlikely
that any combination of methods will remove 100% of all
cell components from a tissue or organ. However, it seems
apparent that methods which remove most or all of the
visible cellular material result in biologic scaffold materials
that are safe for implantation [6].
Conclusion
In this work, we demonstrate effective methods of decel-
lularizing porcine AF tissue while retaining the biologic
composition and ultrastructure of the ECM. Addition-
ally, we describe that biomechanical properties could be
successfully preserved in a decellularized AF scaffold. Al-
though tissue engineering AF tissue remains a challenge,
our data suggest that this scaffold is biocompatible and a
potential candidate for clinical application. Future work
will optimize cell seeding and test the decellularized AF
scaffold in a functional large animal model of disc repair.
This will establish the in vivo regenerative capacity of
the porcine AF scaffold over the longer term. Alternative
surgical options with novel strategies towards anular
repair would significantly improve the chances for the
long-term benefit of discectomy procedures.
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